A drug from AstraZeneca has shown promising results in treating lung cancer. It is the drug Imfinzi that targets aggressive forms of the disease, according to Reuters, Mediafax cites.
The drug shows promise in treating aggressive lung cancer, AstraZeneca representatives announced, according to Reuters. Tests showed it helped improve overall survival. It also had positive results in terms of progression-free survival.
The drug showed “statistically significant and clinically significant improvement,” the late-stage trials showed.
Overall survival is defined as the proportion of patients treated with the drug who survive, while progression-free survival refers to the length of time a person lives with the disease without it getting worse after treatment.
Small cell lung cancer is an extremely aggressive form of cancer that usually recurs and progresses rapidly despite initial response to chemotherapy and radiation therapy, with only 15% to 30% of patients alive five years after diagnosis, a stated AstraZeneca.
2024-04-06 06:29:31
#drug #appeared #promises #treat #lung #cancer #aggressive #phases #stiripesurse.ro
